Table 1. Consequences of mutations that occur in AGS patients on ADAR1 functions.
Identified variants of human ADAR1 that occur in AGS patients | ||||
---|---|---|---|---|
Mutation | Location | Disease Description | Effect on editing | Predicted effect on molecular function |
A870T | – | No significant reduction | Protein destabilization | |
I872T | – | Compound heterozygote with P193A mutation | No significant reduction | Protein destabilization |
R892H | Deaminase | No significant reduction | Disruption of protein interactions with dsRNA | |
K999N | Deaminase (RNA binding loop) | Autosomal recessive | No significant reduction | – |
G1007R | Deaminase (RNA binding loop) | Autosomal dominant | Significant reduction | Potential competitive inhibitor of WT ADAR1 protein |
Y1112H | Deaminase | Autosomal recessive | Not tested | – |
D1113H | Deaminase | Autosomal recessive | No significant reduction | – |